Annual Masterclass 2020
The MPE Annual General Meeting (AGM) 2020 was cancelled due to the COVID-19 outbreak. The educational programme planned to be held in the Annual Masterclass was replace the MPE Webinars series.
MPE AGM 2020 - Webinar on Myeloma and AL amyloidosis treatment updates
MPE AGM 2020 - Webinar on reimbursement and Health Technology Assessment (HTA) in Europe
MPE AGM2020 webinar series - Big data, the Harmony example
Watch the webinar on personalised medicines in myeloma and AL amyloidosis
Minimal Residual Disease (MRD) in myeloma and related diseases
Webinar on the impact of myeloma and AL amyloidosis in carers
Annual Masterclass 2019
MPE AGM 2019 outtakes
Myeloma Treatment Updates
Surrogate end-points in myeloma and AL amyloidosis
Measuring and utilising quality of life
AL Amyloidosis
The role of CAR-T
Annual Masterclass 2018
MPE Capacity Building Programme
Community Advisory Boards and case studies of MPE member groups
Rehabilitation, self-care and quality of life
Journey to a professional and empowered advocate
Clinical trials design and study endpoints
Myeloma related diseases
Drug access and affordability
Coping with a chronic disease
Update on diagnosis and treatment of AL amyloidosis
Annual Masterclass 2017
MPE dialogues - “Where are we now in myeloma and how does the future look like?”
Welcome, introductions and driving throught the conference
The European Atlas of Access to Myeloma Treatment
Update on current diagnosis and treatment of myeloma and related diseases
Clinical trials and drugs under development in myeloma and AL Amyloidosis
Treatment of myeloma in the light of access barriers
Patient advocate development strategies: how can an umbrella organisation help you
Annual Masterclass 2016
Treating myeloma. An update on the current myeloma treatment guidelines
Myeloma and Amyloidosis 101
What is multiple myeloma associated amyloidosis?
Advocacy session 1 – Patient involvement in clinical research
Welcome and introductions
The MPE Atlas: myeloma UK case study
Evidence based advocacy: implementing the MPE Atlas
Atlas Coaching Programme
Myeloma beyond C.R.A.B. An update on the current mueloma diagnosis guidelines